ImCheck Therapeutics Information
Summary
ImCheck Therapeutics is a private company that has been in the industry for 10 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Pierre d'Epenoux. Its headquarters is located at Marseille, Provence-Alpes-Côte-d'Azur, FR. The number of employees ranges from 25 to 100. The annual revenue of ImCheck Therapeutics varies between 100K and 5.0M. Total funding of the company - $86M. To connect with ImCheck Therapeutics employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Specialties
antibodies, immuno-oncology, Immune checkpoint Modulators, Auto-immunity, innate immunity, oncology, cancer, precision-based medicine, adaptative immunity, EVICTIONtrial, ICT01, gamma-deltaTcells
SIC Code
2834, 8731
Founded
2015
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
Contact ImCheck Therapeutics
Organization Website
Social Links
Phone Number
+33 4 13 96 14 90
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2000 | Public Company | 100 - 250 | 34.8M | $211.4M | |
| 2007 | Privately Held | 1 - 25 | 5.6M | $130.7M | |
| 2014 | Privately Held | 25 - 100 | 4.5M | $14M | |
| 2014 | Public Company | 25 - 100 | 9.3M | $131M | |
| 1999 | Public Company | 100 - 250 | 79.4M | $141.4M | |
| 2010 | Privately Held | 25 - 100 | 4.2M | $44.6M | |
| 1999 | Public Company | 100 - 250 | 9.5M | $533.1M | |
| 2002 | Public Company | 25 - 100 | 10.3M | $204.1M | |
| 2004 | Privately Held | 25 - 100 | 21.5M | $0 | |
| 2008 | - | 500-1000 | - | $- | |
| 2007 | - | 100-200 | - | $- | |
| 1979 | - | 200-500 | - | $- | |
| 2008 | - | 200-500 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Length of Employment
